ArticleCell reports2024

Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progression.

Juan F Codocedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.